Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease
RecruitingNCT05904132Phase: NAStarted 2025-01-31
Summary
The project is a placebo-controlled study that aims to use closed-loop transcranial alternating current stimulation (tACS) to study patients with symptoms of mild cognitive impairment which is likely
Eligibility
Sex
ALL
Min Age
50 Years
Max Age
80 Years
Locations
Massachusetts General HospitalCharlestown, Massachusetts, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05904132